Correlation Between Enlivex Therapeutics and Pluri

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Enlivex Therapeutics and Pluri at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enlivex Therapeutics and Pluri into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enlivex Therapeutics and Pluri Inc, you can compare the effects of market volatilities on Enlivex Therapeutics and Pluri and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enlivex Therapeutics with a short position of Pluri. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enlivex Therapeutics and Pluri.

Diversification Opportunities for Enlivex Therapeutics and Pluri

0.04
  Correlation Coefficient

Significant diversification

The 3 months correlation between Enlivex and Pluri is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Enlivex Therapeutics and Pluri Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pluri Inc and Enlivex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enlivex Therapeutics are associated (or correlated) with Pluri. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pluri Inc has no effect on the direction of Enlivex Therapeutics i.e., Enlivex Therapeutics and Pluri go up and down completely randomly.

Pair Corralation between Enlivex Therapeutics and Pluri

Given the investment horizon of 90 days Enlivex Therapeutics is expected to under-perform the Pluri. But the stock apears to be less risky and, when comparing its historical volatility, Enlivex Therapeutics is 1.3 times less risky than Pluri. The stock trades about -0.47 of its potential returns per unit of risk. The Pluri Inc is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  432.00  in Pluri Inc on August 27, 2024 and sell it today you would earn a total of  58.00  from holding Pluri Inc or generate 13.43% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Enlivex Therapeutics  vs.  Pluri Inc

 Performance 
       Timeline  
Enlivex Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Enlivex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Pluri Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pluri Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Pluri is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Enlivex Therapeutics and Pluri Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Enlivex Therapeutics and Pluri

The main advantage of trading using opposite Enlivex Therapeutics and Pluri positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enlivex Therapeutics position performs unexpectedly, Pluri can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pluri will offset losses from the drop in Pluri's long position.
The idea behind Enlivex Therapeutics and Pluri Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Bonds Directory
Find actively traded corporate debentures issued by US companies